皮膚生検の世界市場

皮膚生検の世界市場は2030年までに1億4,920万米ドルに達する見込み

2024年に1億1,690万米ドルと推定される皮膚生検の世界市場は、分析期間2024-2030年にCAGR 4.1%で成長し、2030年には1億4,920万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるShave Biopsyは、CAGR 3.2%を記録し、分析期間終了までに7,540万米ドルに達すると予測されます。パンチ生検セグメントの成長率は、分析期間でCAGR 5.3％と推定されます。

米国市場は3,190万米ドルと推定、中国はCAGR 7.4％で成長予測

米国の皮膚生検市場は、2024年に3,190万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 7.4%で推移し、2030年には予測市場規模3,020万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8％と3.2％と予測されています。欧州では、ドイツがCAGR 2.4%で成長すると予測されています。

世界の「皮膚生検」市場- 主要動向と促進要因のまとめ

皮膚生検はなぜ皮膚科治療の診断の要となったのか？

皮膚生検は、良性腫瘍や炎症性疾患から自己免疫疾患や様々な皮膚がんに至るまで、幅広い皮膚疾患に関する重要な洞察を提供し、現代の皮膚科における主要な診断技術としての地位を確固たるものにしています。剃毛生検、パンチ生検、摘出生検、切開生検などの方法で行われ、皮膚組織の採取と病理組織学的分析が可能です。生検は低侵襲で短時間、しかも外来で行えるため、臨床医にとって実用的で利用しやすい手段です。皮膚がん、特にメラノーマ、基底細胞がん、扁平上皮がんの世界の罹患率の上昇により、早期かつ正確な生検による診断が医学的に必要となっています。さらに、乾癬、湿疹、エリテマトーデス、扁平苔癬などの慢性皮膚疾患では、治療を調整するために生検による確認が必要となることが多いです。プレシジョン・メディシンの時代には、生検は診断だけでなく予後予測も可能になり、バイオマーカーの発見、遺伝子解析、免疫組織化学的プロファイリングが可能になります。真菌性皮膚症、ハンセン病、皮膚結核などの感染症も、流行地域では皮膚生検が必要です。その有用性は疾患の種類、年齢層、ヘルスケア環境を超えており、皮膚生検はタイムリーで確実な皮膚科診断と治療計画に不可欠です。

技術の進歩は皮膚生検手技の精度と効率をどのように高めているか？

最近の技術革新は、皮膚生検を手作業による視覚的ガイドからデータ豊富な診断プロセスへと変化させています。高解像度のダーモスコピーとデジタル画像システムにより、皮膚科医は生検を行う前に疑わしい病変をより正確に特定できるようになりました。ロボット支援パンチ生検ツールやマイクロトーム一体型皮膚スキャナーにより、手技の一貫性が向上し、組織損傷が減少しています。組織病理ワークフローも、AIと機械学習を用いて組織サンプルをスキャン、分類、解釈するデジタル病理プラットフォームによって、より正確かつ迅速にアップグレードされています。ホールスライドイメージングは、クラウドベースのデータ共有と相まって、複雑な症例の遠隔診察やセカンドオピニオンを可能にしています。一方、粘着パッチ生検（テープストリッピングなど）のような低侵襲技術は、特に小児科や美容皮膚科において、痛みを伴わずに表在細胞を採取できることから注目を集めています。分子診断アッセイやゲノムシークエンシングが生検サンプルで日常的に実施されるようになり、特にメラノーマや稀な皮膚リンパ腫において、個別化治療に役立つ変異や免疫シグネチャーが明らかになっています。シングルユースの滅菌器具、内蔵麻酔薬、迅速固定液など、生検キットの自動化により、クリニックでの処置が合理化されています。これらの進歩は、診断の歩留まりを向上させるだけでなく、患者の安全性、満足度、転帰を改善しています。

皮膚生検は臨床・公衆衛生分野でどのような役割を果たしていますか？

皮膚生検は、世界中の皮膚科クリニック、腫瘍センター、病理検査室、学術機関、公衆衛生プログラムにおいて、極めて重要な役割を果たしています。先進ヘルスケアシステムでは、生検は皮膚病理ワークフローに不可欠であり、皮膚がんや自己免疫疾患における治療決定の指針となっています。腫瘍学では、生検は腫瘍の病期分類、手術断端の評価、治療効果の評価に不可欠です。免疫皮膚科では、複雑な水疱性疾患、血管炎、結合組織障害の診断をサポートしています。小児皮膚科医は、良性の小児発疹と早期発症の遺伝性症候群を区別するために生検を利用しています。恵まれない遠隔地では、生検キットを装備した移動式皮膚科ユニットが、リーシュマニア症やマイセトーマなどの顧みられない熱帯病のスクリーニングや診断に役立っています。一般向けの皮膚がん検診キャンペーンでは、生検機能を組み込んで即日診断やトリアージを行うことが多いです。生検はまた、新しい皮膚科治療の臨床試験においても重要な役割を果たしており、有効性のベースラインおよび治療後のベンチマークとしての役割を果たしています。さらに、皮膚生検は、新しい生物学的製剤、外用治療薬、ワクチンの開発に役立つ、学術研究および製薬研究の基礎となっています。早期発見から精密腫瘍学、治療研究まで、その分野横断的な重要性は、現代のヘルスケア・エコシステムにおける不可欠な役割を浮き彫りにしています。

皮膚生検市場の成長は、皮膚科疾患の動向、技術統合、ヘルスケアへのアクセス拡大を反映するいくつかの要因によって牽引されています。

高齢化、紫外線暴露の増加、ライフスタイルの変化などにより、皮膚がん、特にメラノーマの罹患率が世界的に上昇していることが大きな成長要因となっています。認知度の向上と積極的な皮膚健康行動によって皮膚科サービスも並行して成長し、臨床と美容の両面で皮膚生検の件数が増加しています。技術統合、特にデジタル病理学、AI支援診断、分子解析は、生検の有用性の範囲と効率を拡大し、ヘルスケア層全体への幅広い採用を促しています。加えて、外来や外来での皮膚科サービスの利用が可能になったことで、生検がより身近なものとなり、病院外での手技の成長にも拍車をかけています。特に若年層や環境ストレスによる自己免疫疾患や炎症性皮膚疾患の急増は、病理組織学的確認の必要性をさらに高めています。新興国におけるヘルスケア支出とインフラの増加は、未診断のがんや放置された皮膚疾患の負担を軽減する努力と相まって、アジア太平洋、ラテンアメリカ、アフリカの市場成長を促進しています。一方、新しい生検ツールや非侵襲的サンプリング技術の規制当局による承認は、製品ポートフォリオを多様化し、手技の障壁を軽減しています。疾病の蔓延、診断技術革新、ヘルスケアの分散化、世界のアクセスといったこれらの交錯する動向が、皮膚生検市場の力強い持続的拡大の原動力となっています。

セグメント

タイプ（剃毛生検、パンチ生検、切開生検）、適応症（皮膚がん、光線性角化症、皮膚炎、その他の適応症）、エンドユーザー（病院＆クリニック、診断研究所、その他のエンドユーザー）

調査対象企業の例（全34件）

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

関税影響係数

Global Industry Analystsは、本社国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Skin Biopsy Market to Reach US$149.2 Million by 2030

The global market for Skin Biopsy estimated at US$116.9 Million in the year 2024, is expected to reach US$149.2 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Shave Biopsy, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$75.4 Million by the end of the analysis period. Growth in the Punch Biopsy segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Million While China is Forecast to Grow at 7.4% CAGR

The Skin Biopsy market in the U.S. is estimated at US$31.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$30.2 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global "Skin Biopsy" Market - Key Trends & Drivers Summarized

Why Has Skin Biopsy Become The Diagnostic Cornerstone Of Dermatological Care?

Skin biopsy has solidified its position as a primary diagnostic technique in modern dermatology, offering critical insights into a wide range of skin conditions, from benign growths and inflammatory disorders to autoimmune diseases and various forms of skin cancer. Performed using methods such as shave biopsy, punch biopsy, excisional biopsy, or incisional biopsy, the procedure allows for the extraction and histopathological analysis of skin tissue. It is minimally invasive, quick, and can be done in outpatient settings, making it a practical and accessible tool for clinicians. The rising global incidence of skin cancers-especially melanoma, basal cell carcinoma, and squamous cell carcinoma-has made early and accurate biopsy-driven diagnosis a medical necessity. Additionally, chronic dermatological conditions like psoriasis, eczema, lupus erythematosus, and lichen planus often require biopsy confirmation to tailor treatment. In the age of precision medicine, biopsies are not only diagnostic but also prognostic, enabling biomarker discovery, genetic analysis, and immunohistochemical profiling. Infections like fungal dermatoses, leprosy, and cutaneous tuberculosis also necessitate skin biopsies in endemic regions. With their utility spanning across disease types, age groups, and healthcare environments, skin biopsies are indispensable for timely, definitive dermatological diagnosis and treatment planning.

How Are Technological Advances Enhancing Accuracy And Efficiency In Skin Biopsy Procedures?

Recent technological innovations are transforming skin biopsy from a manual, visually guided procedure into a data-rich diagnostic process. High-resolution dermoscopy and digital imaging systems now allow dermatologists to identify suspicious lesions with greater precision before a biopsy is performed. Robotics-assisted punch biopsy tools and microtome-integrated skin scanners are improving procedural consistency and reducing tissue damage. Histopathology workflows have also been upgraded through digital pathology platforms that use AI and machine learning to scan, classify, and interpret tissue samples with enhanced accuracy and speed. Whole-slide imaging, coupled with cloud-based data sharing, allows for remote consultations and second opinions in complex cases. Meanwhile, minimally invasive techniques such as adhesive patch biopsies (e.g., tape stripping) are gaining attention for their ability to collect superficial cells painlessly, especially in pediatric and cosmetic dermatology. Molecular diagnostic assays and genomic sequencing are now routinely conducted on biopsy samples, revealing mutations and immune signatures that inform personalized treatment-especially in melanomas and rare cutaneous lymphomas. Automation in biopsy kits, including single-use sterilized instruments, built-in anesthetics, and rapid fixation solutions, is streamlining in-clinic procedures. Together, these advancements are not only enhancing diagnostic yield but also improving patient safety, satisfaction, and outcomes.

Where Is Skin Biopsy Playing A Transformative Role Across Clinical And Public Health Sectors?

Skin biopsy is playing a pivotal role across dermatology clinics, oncology centers, pathology labs, academic institutions, and public health programs worldwide. In developed healthcare systems, biopsies are integral to dermatopathology workflows, guiding treatment decisions in skin cancers and autoimmune conditions. In oncology, biopsies are essential for staging tumors, evaluating surgical margins, and assessing treatment response. In immunodermatology, they support the diagnosis of complex blistering diseases, vasculitis, and connective tissue disorders. Pediatric dermatologists rely on biopsies to distinguish between benign pediatric rashes and early-onset genetic syndromes. In underserved and remote areas, mobile dermatology units equipped with biopsy kits are helping screen and diagnose neglected tropical diseases, including leishmaniasis and mycetoma. Public skin cancer screening campaigns often integrate biopsy capabilities to provide same-day diagnosis and triage. Biopsies also play a critical role in clinical trials for new dermatological therapies, serving as baseline and post-treatment benchmarks for efficacy. Furthermore, skin biopsies are foundational in academic and pharmaceutical research, aiding in the development of new biologics, topical treatments, and vaccines. Their cross-disciplinary importance-from early detection to precision oncology and therapeutic research-highlights their indispensable role in modern healthcare ecosystems.

The Growth In The Skin Biopsy Market Is Driven By Several Factors That Reflect Dermatological Disease Trends, Technological Integration, And Healthcare Accessibility Expansion

A significant growth driver is the global rise in skin cancer incidence, especially melanoma, driven by aging populations, increased UV exposure, and lifestyle changes. Parallel growth in dermatology services, driven by improved awareness and proactive skin health behaviors, has led to a higher volume of skin biopsies in both clinical and cosmetic settings. Technological integration-particularly digital pathology, AI-assisted diagnostics, and molecular analysis-has expanded the scope and efficiency of biopsy utility, encouraging broader adoption across healthcare tiers. Additionally, the growing availability of dermatology services in ambulatory and outpatient settings has made biopsies more accessible, fueling procedural growth even outside of hospitals. The surge in autoimmune and inflammatory skin disorders, especially among younger demographics and due to environmental stressors, further amplifies the need for histopathological confirmation. Increasing healthcare spending and infrastructure in emerging economies, combined with efforts to reduce the burden of undiagnosed cancers and neglected skin conditions, are driving market growth in Asia-Pacific, Latin America, and Africa. Meanwhile, regulatory approval of newer biopsy tools and non-invasive sampling techniques is diversifying product portfolios and reducing procedural barriers. These intersecting trends-disease prevalence, diagnostic innovation, healthcare decentralization, and global access-are powering the strong, sustained expansion of the skin biopsy market.

SCOPE OF STUDY:

The report analyzes the Skin Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy); Indication (Skin Cancer, Actinic Keratosis, Dermatitis, Other Indications); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Skin Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Skin Cancer and Chronic Dermatological Conditions Drives Biopsy Demand
  • Growing Awareness and Early Diagnosis Campaigns Propel Skin Biopsy Procedure Volume
  • Advancements in Minimally Invasive Biopsy Devices Improve Patient Acceptance and Outcomes
  • Increased Adoption of Teledermatology and AI Diagnostics Strengthens Screening Rates
  • Integration of Biopsy Services into Primary Care Clinics Expands Patient Access
  • Dermatology-Focused Clinical Trials and R&D Stimulate Market for Diagnostic Biopsies
  • Regulatory Approvals for New Biopsy Tools Accelerate Technology Penetration
  • Rising Demand for Histopathological Analysis in Aesthetic Dermatology Expands Market Scope
  • Expansion of Skin Biopsy Use in Personalized Medicine Drives Precision Diagnostics
  • Aging Population with Higher Incidence of Skin Disorders Sustains Long-Term Demand
  • Rapid Growth in Outpatient Dermatology Centers Spurs Procedural Volume
  • Health Insurance Coverage Expansion in Emerging Markets Improves Accessibility to Biopsy Services
  • Technological Improvements in Imaging-Guided Biopsies Enhance Diagnostic Accuracy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Skin Biopsy Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Shave Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Punch Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Excisional Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Skin Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Actinic Keratosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION